Technology | May 18, 2010

Proton Therapy Becoming More Accessible to U.S. Patients

A proton therapy treatment vault at the Rinecker Proton Therapy Center (RPTC) in Munich, Germany.

May 18, 2010 - Proton beam therapy is becoming more accessible in the United States.

While proton beam therapy has proved to be more precise in delivering dose to tumors compared to conventional external beam radiation, the larger proton beam accelerator is more expensive, and the process requires special training.

However, recent advances in the technology is making it more accessible. Varian Medical Systems is introducing the fully-integrated ProBeam proton therapy system at the 2010 Particle Therapy Co-operative Group (PT-COG) meeting here this week. ProBeam is designed to simplify the proton therapy treatment process for clinicians and patients alike.

The system incorporates imaging, gating, robotic patient positioning, treatment planning and oncology information software to enhance treatment quality for patients and workflow efficiency for clinicians.

The integrated system can be used for all forms of advanced proton therapy, including image-guided proton therapy and intensity-modulated proton therapy.

The ProBeam system incorporates Dynamic Peak integrated scanning technology, which is designed to paint a precise radiation dose on the target volume, enabling intensity modulated proton therapy. The system also incorporates proprietary pencil-beam scanning technology, which allows for precise dose distribution.

Using Varian's 250 MeV super-conducting cyclotron and features, the ProBeam system includes a streamlined treatment console with a modern, graphical interface that consolidates all controls for imaging, treatment and motion management. Treatment process and workflows use a follow the light-guidance system that is designed to enhance usability and promote safety by guiding therapists through the steps of even the most complex treatments.

The ProBeam interface has the same design as Varian's recently-announced TrueBeam system for radiation therapy and TrueBeam STx system for radiosurgery.

For more information: www.varian.com

Related Content

DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing  synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of  the anatomy.

A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of the anatomy.

Feature | Radiation Oncology | May 29, 2019 | By Jeff Zagoudis
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...